 |
| |
| Dec-14-18 08:00AM | iBio Provides Status Update on its Continuing Litigation Against Fraunhofer GlobeNewswire |
| Dec-03-18 08:00AM | iBio to Present at Brazilian Ministry of Healths Plant-Made Pharmaceutical Meeting GlobeNewswire |
| Oct-02-18 08:00AM | iBio and CC-Pharming Hold First Design and Strategy Meeting GlobeNewswire +13.53% |
| Aug-22-18 04:10PM | iBio, Inc. Announces NYSE American Acceptance of Plan of Compliance GlobeNewswire |
| Jul-09-18 08:00AM | iBio Establishes Strategic Commercial Relationship with CC-Pharming Ltd. of Beijing, China GlobeNewswire +8.00% |
| Jun-27-18 07:20AM | Free Technical Research on Nektar Therapeutics and Three More Biotech Equities ACCESSWIRE |
| Jun-26-18 06:59PM | iBio, Inc. Closes $16,000,000 Public Offering GlobeNewswire |
| Jun-22-18 07:26AM | iBio, Inc. Prices $16,000,000 Public Offering GlobeNewswire |
| Jun-08-18 04:30PM | iBio, Inc. Announces Completion of 1-For-10 Reverse Stock Split GlobeNewswire |
| 04:01PM | iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan GlobeNewswire |
| Jun-05-18 08:30AM | iBio and ONEWAY Diagnostica Develop New Products for Brazil GlobeNewswire +10.21% |
| Jun-04-18 05:46PM | Why iBio Incs (NYSEMKT:IBIO) Ownership Structure Is Important Simply Wall St. |
| May-31-18 08:30AM | iBio, Inc. Announces Reverse Stock Split GlobeNewswire -7.40% |
| May-24-18 07:15AM | Complimentary Technical Snapshots on Heat Biologics and Three More Biotech Stocks ACCESSWIRE |
| Apr-11-18 01:27PM | Should iBio Incs (NYSEMKT:IBIO) Recent Earnings Decline Worry You? Simply Wall St. -9.57% |
| Mar-14-18 08:30AM | iBio Selects Lead Candidate for its Fibrosis Therapeutics Program GlobeNewswire |
| Mar-12-18 08:30AM | iBio Patent Issues in China on Protein Glycosylation Modification GlobeNewswire |
| Mar-07-18 08:45AM | iBio Expands Antibody Development and Production Services to Include Fc Fusion Therapeutics GlobeNewswire +26.09% |
| Dec-18-17 03:44PM | ETFs with exposure to iBio, Inc. : December 18, 2017 Capital Cube +5.91% |
| Dec-08-17 02:53PM | iBio Inc (IBIO): Does -31.1% EPS Decline Lately Make It An Underperformer? Simply Wall St. |
| 01:03PM | ETFs with exposure to iBio, Inc. : December 8, 2017 Capital Cube |
| Nov-30-17 04:15PM | iBio, Inc. Closes $4,500,000 Offering of Common Stock GlobeNewswire |
| Nov-29-17 09:00AM | iBio, Inc. Prices $4,500,000 Firm Commitment Offering of Common Stock GlobeNewswire -31.61% |
| Nov-28-17 05:07PM | iBio, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire |
| Nov-27-17 02:12PM | ETFs with exposure to iBio, Inc. : November 27, 2017 Capital Cube |
| Nov-14-17 02:27PM | ETFs with exposure to iBio, Inc. : November 14, 2017 Capital Cube |
| Nov-13-17 09:20AM | iBio, Inc. :IBIO-US: Earnings Analysis: Q1, 2018 By the Numbers : November 13, 2017 Capital Cube |
| Nov-08-17 12:00PM | AEMD: Upcoming FDA Meeting Expected to Define U.S. Regulatory Pathway Zacks Small Cap Research |
| Nov-06-17 05:00PM | iBio, Inc. Initiates Litigation Against Fraunhofer-Gesellschaft in Delaware Chancery Court GlobeNewswire |
| Oct-30-17 08:30AM | iBio CDMO President to Co-Chair South African Molecular Pharming Conference GlobeNewswire |
| Oct-24-17 09:39AM | ETFs with exposure to iBio, Inc. : October 24, 2017 Capital Cube -5.51% |
| Oct-23-17 08:00AM | IBio, Aethlon Agreement, The Biologics Market, and Analysts Target, CFB-03 Update ACCESSWIRE |
| Oct-18-17 07:00AM | Featured Company News - iBio Announces Large-Scale Manufacturing Collaboration with Aethlon Medical ACCESSWIRE |
| Oct-16-17 07:15AM | iBio Announces Manufacturing Collaboration with Aethlon Medical GlobeNewswire +5.00% |
| 07:15AM | Aethlon Medical Announces Large-Scale Production Collaboration PR Newswire |
| Oct-13-17 10:56AM | ETFs with exposure to iBio, Inc. : October 13, 2017 Capital Cube |
| Oct-05-17 05:36PM | What Are The Drivers Of iBio Incs (IBIO) Risks? Simply Wall St. |
| Oct-04-17 09:00AM | iBio, Inc. :IBIO-US: Earnings Analysis: Q4, 2017 By the Numbers : October 4, 2017 Capital Cube |
| Oct-02-17 10:54AM | ETFs with exposure to iBio, Inc. : October 2, 2017 Capital Cube |
| 08:30AM | iBio Appoints James Abbey, Ph.D. as Vice President of Strategic Business Development GlobeNewswire |
| Sep-20-17 05:40PM | ETFs with exposure to iBio, Inc. : September 20, 2017 Capital Cube +18.81% |
| 08:00AM | iBio, Inc. Intellectual Property Update GlobeNewswire |
| Sep-19-17 05:55PM | iBio Makes NYSE MKT Section 610(b) Public Announcement GlobeNewswire -11.35% |
| 02:27PM | iBio, Inc. :IBIO-US: Earnings Analysis: 2017 By the Numbers : September 19, 2017 Capital Cube |
| Sep-18-17 08:00AM | iBio and TheoremDx Collaborate to Develop Proteins for Rapid Diagnostics Testing Products GlobeNewswire +22.84% |
| Jul-25-17 07:12AM | AzarGen Biotechnologies Granted European Patent for Plant-Made PRODUCTION OF RECOMBINANT HUMAN SURFACTANT PROTEIN-B PR Newswire +24.24% |
| Jul-24-17 08:30AM | iBio, Inc. Enters into Common Stock Purchase Agreement for Up to $16.0 Million with Lincoln Park Capital GlobeNewswire -13.55% |
| Jul-12-17 01:00PM | Wednesdays Biotech Movers: Ibio Inc (IBIO) Rallies, Ocular Therapeutix Inc (OCUL) Tumbles, Alder Biopharmaceuticals Inc (ALDR) Dives SmarterAnalyst +13.57% |
| 08:32AM | US Patent Granted to AzarGen Biotechnologies for Synthetic Promoter Technology PR Newswire |
| Jul-10-17 02:38PM | ETFs with exposure to iBio, Inc. : July 10, 2017 Capital Cube |
| Jun-05-17 02:21PM | ETFs with exposure to iBio, Inc. : June 5, 2017 Capital Cube +9.06% |
| 08:30AM | iBio, Inc. to Present Plant-Made Pharmaceutical Platform at Plant-Based Vaccines, Antibodies & Biologics Conference GlobeNewswire |
| May-25-17 12:41PM | ETFs with exposure to iBio, Inc. : May 25, 2017 Capital Cube |
| May-24-17 10:27AM | iBio, Inc. :IBIO-US: Earnings Analysis: Q3, 2017 By the Numbers : May 24, 2017 Capital Cube |
| May-04-17 04:01PM | iBio, Inc. Provides Corporate Update at Annual Shareholders Meeting Marketwired |
| Apr-25-17 03:36PM | ETFs with exposure to iBio, Inc. : April 25, 2017 Capital Cube |
| Apr-07-17 04:50PM | ETFs with exposure to iBio, Inc. : April 7, 2017 Capital Cube |
| Mar-27-17 03:59PM | ETFs with exposure to iBio, Inc. : March 27, 2017 Capital Cube |
| 03:59PM | ETFs with exposure to iBio, Inc. : March 27, 2017 |
| Mar-20-17 12:08PM | iBio, Inc. :IBIO-US: Earnings Analysis: Q2, 2017 By the Numbers : March 20, 2017 Capital Cube |
| 12:08PM | iBio, Inc. :IBIO-US: Earnings Analysis: Q2, 2017 By the Numbers : March 20, 2017 |
| Mar-06-17 05:01PM | IBIO, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits |
| Feb-25-17 01:04PM | IBIO, INC. Financials |
| Feb-24-17 05:04PM | IBIO, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Ma |
| Feb-21-17 04:06PM | IBIO, INC. Files SEC form 10-Q, Quarterly Report |
| Jan-27-17 08:30AM | Court Schedules Hearing To Consider Approval Of Settlement Of Derivative Action Marketwired |
| Jan-25-17 01:18PM | ETFs with exposure to iBio, Inc. : January 25, 2017 Capital Cube |
| 01:18PM | ETFs with exposure to iBio, Inc. : January 25, 2017 |
| Jan-04-17 11:06AM | ETFs with exposure to iBio, Inc. : January 4, 2017 |
| Dec-21-16 12:26PM | ETFs with exposure to iBio, Inc. : December 21, 2016 Capital Cube |
| 12:26PM | ETFs with exposure to iBio, Inc. : December 21, 2016 |
| Dec-09-16 12:19PM | ETFs with exposure to iBio, Inc. : December 9, 2016 Capital Cube |
| 12:19PM | ETFs with exposure to iBio, Inc. : December 9, 2016 |
| Dec-08-16 08:14AM | iBio, Inc. :IBIO-US: Earnings Analysis: Q1, 2017 By the Numbers : December 8, 2016 Capital Cube |
| 08:14AM | iBio, Inc. :IBIO-US: Earnings Analysis: Q1, 2017 By the Numbers : December 8, 2016 |
| Nov-21-16 08:31AM | Another iBio Plague Vaccine Patent Issues Marketwired |
| Nov-18-16 05:06PM | IBIO, INC. Files SEC form 10-Q, Quarterly Report |
| Nov-10-16 08:31AM | iBio Expands Product Development Capacity of cGMP Plant Marketwired |
| Nov-07-16 12:32PM | ETFs with exposure to iBio, Inc. : November 7, 2016 Capital Cube |
| 12:32PM | ETFs with exposure to iBio, Inc. : November 7, 2016 |
| Oct-25-16 02:48PM | ETFs with exposure to iBio, Inc. : October 25, 2016 Capital Cube |
| 02:48PM | ETFs with exposure to iBio, Inc. : October 25, 2016 |
| Oct-24-16 09:10AM | iBio, Inc. :IBIO-US: Earnings Analysis: 2016 By the Numbers : October 24, 2016 |
| Oct-13-16 04:07PM | IBIO, INC. Files SEC form 10-K, Annual Report |
| Sep-29-16 08:30AM | iBio Proprietary Technology Advances Neonatal Respiratory Distress Syndrome Drug Development for South African Biotech Company AzarGen Biotechnologies (Pty) Ltd Marketwired |
| Aug-15-16 08:30AM | Implications of Court Decision in Favor of iBio Against Fraunhofer Marketwired |
| Aug-04-16 08:31AM | iBio, Inc.'s Claims Against Fraunhofer Affirmed by Delaware Chancery Court Marketwired |
| Jul-05-16 08:31AM | iBio, Inc. Receives FDA Orphan Drug Designation for Fibrosis Product Candidate Marketwired |
| Jun-29-16 08:31AM | iBio, Inc. Receives New Patent for Its Biotherapeutic Products for Treatment of Fibrosis Marketwired |
| Jun-07-16 08:31AM | Texas A&M University System and iBio Execute Joint Development Agreement for Plant-Produced Pharmaceuticals Marketwired |
| May-23-16 04:46PM | IBIO, INC. Files SEC form 10-Q, Quarterly Report |
| Apr-08-16 06:04AM | IBIO, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financi |
| Apr-07-16 05:46PM | iBio, Inc. Holds Annual Meeting in College Station, Texas Marketwired |
| Mar-02-16 04:04PM | IBIO, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| Feb-26-16 12:28PM | iBio, Inc. Earnings Analysis: Q2, 2016 By the Numbers |
| Feb-22-16 06:04AM | IBIO, INC. Files SEC form 10-Q, Quarterly Report |
| Feb-01-16 12:08PM | Largest Insiders' Trades of the Last Week |
| Jan-29-16 04:10PM | IBIO, INC. Files SEC form 8-K, Shareholder Director Nominations, Other Events |
| Jan-14-16 09:08AM | IBIO, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Re |
| 09:00AM | iBio Forms Joint Venture CMO for Large-Scale Pharmaceuticals Manufacturing in Green Plants and Accepts Additional Investment Marketwired |
|
|
|
|
| iBio, Inc., a biotechnology company, provides product development and manufacturing services to clients, collaborators, and third-party customers in the United States and internationally. The company's services cover the stages of product selection, regulatory approval, and commercial product launch. Its lead therapeutic candidate is IBIO-CFB03 for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and other fibrotic diseases. It is also developing vaccine candidates for third parties. The company has collaboration agreements with ONEWAY Diagnostica; AzarGen Biotechnologies (Pty) Ltd; The Texas A&M University System; and Fraunhofer Center for Molecular Biotechnology, as well as strategic relationship with CC-Pharming Ltd. In addition, it offers a range of product and process development, analytical, and manufacturing services. iBio, Inc. is headquartered in New York, New York. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Eastern Capital LTD | 10% Owner | Jul 12 | Buy | 0.90 | 2,200,000 | 1,980,000 | 8,457,734 | Jul 13 04:06 PM | | Eastern Capital LTD | 10% Owner | Jun 26 | Buy | 0.90 | 1,683,334 | 1,515,001 | 6,257,734 | Jun 28 06:03 PM |
|
|
|
|
|
|
